Recurrent Osteosarcoma Active Not Recruiting Phase 2 Trials for Sargramostim (DB00020)

Also known as: Osteosarcoma recurrent / Osteogenic sarcoma recurrent

IndicationStatusPhase
DBCOND0028757 (Recurrent Osteosarcoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02484443Dinutuximab in Combination With Sargramostim in Treating Patients With Recurrent OsteosarcomaTreatment